摘要
慢性乙型活动性肝炎５１例，随机分为２组，治疗组２５例，每次服红宝（枸杞多糖）２粒，每日２次，干扰素α－２ｂ，每次３００万Ｕ，每周３次，连用１６周．对照组２６例，每次服肝必复１４０ｍｇ，每日３一次，连用１６周，治毕６个月后随访．结果显示治疗组ＨＢＶＤＮＡ和ＨＢｅＡｇ的阴转率明显高于对照组，分别为７２％和２６％，１１．５％和１５．４％（Ｐ＜０．００１），总有效率达６８％，不良反应轻．
Fifty one patients with chronic active hepatitis B were randomly divided into two groups. The 25 patients were treated with mocrea (lytium barbarum polysaccharides dose 2 pills po. bid) and interferon α-2b (3 million units tiw. )for 16 wk in the treated group. Other similar 26patients received ganbifu 140mg. po. tid for 16 wk served as control. Follow-up study at 6th monthsfter completion of treatment. Results showed that seroconversion to negative HBV DNA and HBeAg in the treated group were marked higher than those in the control group (72% and 76% vs11.5% and 15. 4%. respectively P<0. 001 ). The total effective rate was 69%. Adverse reactionswere mild.
